BIOSKRYB GENOMICS Trademark Renewal for Medical Services

ChangeBridge: Trademarks - Medical Services (Class 044)

Published March 26th, 2026

Detected March 27th, 2026

Summary

The United States Patent and Trademark Office has renewed the trademark 'BIOSKRYB GENOMICS' for services including medical testing, genetic analysis, and research. The renewal is effective March 26, 2026, and covers a broad range of diagnostic, analytical, and research services in the fields of genetics and genomics.

View original document View source feed page

What changed

The USPTO has processed a renewal for the trademark 'BIOSKRYB GENOMICS', originally registered under Class 044 for medical services. This renewal, effective March 26, 2026, confirms the continued protection for a wide array of services including medical testing for diagnostic and treatment purposes, medical analysis, genetic testing, and various research services related to genetics, genomics, and related fields.

This renewal signifies that the trademark owner has maintained the necessary filings and fees to keep the mark active for its specified services. For entities operating in the medical testing and genetic analysis space, this indicates that 'BIOSKRYB GENOMICS' remains a protected brand, and any new services or products launched under this mark will continue to be defended by the USPTO. No new compliance obligations are imposed by this renewal itself, but it reinforces the existing intellectual property landscape for these services.

Source document (simplified)

← USPTO Trademark Applications

BIOSKRYB GENOMICS

Renewed TM90466612 Kind: renewed Mar 26, 2026

Abstract

Medical testing for diagnostic or treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic testing, monitoring and reporting services; Gene and genetic testing apparatus in the nature of apparatus for DNA and RNA testing for medical and scientific purposes; medical apparatus and instruments, namely, a thermal mixer and plate spinner for the amplification and recovery of genomic material for medical purposes; medical apparatus and instruments, namely, magnetic plates for use with magnetic and paramagnetic beads for the processing, purification, and cleanup of samples containing genomic material, including material from single cells; Genomic analysis and sequencing services for scientific, medical, and research purposes; medical and scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; nucleic acid and ribonucleic acid analysis services for medical and scientific research purposes; providing medical and scientific research information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta genomics, meta-transcriptomics, and microbiomics; medical and scientific research in connection with high-quality single-cell and low input DNA amplification, primary template-directed amplification (PTA) reaction and library cleanup, optimum bead cleanup performance, single-cell and low-input transcriptional profiling, and combined genome and transcriptome profiling; medical and scientific research in connection with genome amplification to detect genetic variants in cells; medical and scientific research in connection with measuring genetic diversity in single cells; medical and scientific research in connection with primary template-directed amplification for use in connection with single cells and ultra-low DNA input samples; medical and scientific research for the purpose of elevating single cell genome variants for the purpose of genome amplification; DNA analysis and sequencing services for scientific, medical, and research purposes; research, development and scientific consultancy in the field of genomics; medical research, namely, compiling data for research purposes in the field of genomics; providing medical research information in the field of genomics, gene therapy, cell therapy for medical purposes; providing on-line non-downloadable software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta transcriptomics, and microbiomics; platform as a service (PAAS) featuring computer software platforms for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; providing temporary use of non-downloadable computer software for bioinformatic DNA sequencing analysis for the purpose of allowing users to evaluate data quality, compare results between cells and samples, and integrate multi-omics data; providing temporary use of non-downloadable computer software for bioinformatic DNA sequencing analysis for evaluating data, namely, sequencing alignment, coverage, and single nucleotide, structural, and copy number variant calling metrics; providing temporary use of non-downloadable computer software for genomic analysis and sequencing for scientific, medical, and research purposes; providing temporary use of non-downloadable computer software for medic...